Related Experiment Video
Updated: Feb 11, 2026

Studying Brain Function in Children Using Magnetoencephalography
Published on: April 8, 2019
Human Parechovirus Infection in Children in Taiwan: a Retrospective, Single-Hospital Study
Jenn-Tzong Chang1,2, Yao-Shen Chen3,2, Bao-Chen Chen4
1Department of Pediatrics, Kaohsiung Veterans General Hospital.
Insights
Human parechovirus (HPeV) infections are common in Taiwanese children. Hospital-acquired HPeV infections pose a significant risk, particularly for infants under three months old.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Human parechovirus (HPeV) is a significant cause of illness in children.
- Understanding HPeV epidemiology and clinical manifestations in Taiwan is crucial for public health.
Purpose of the Study:
- To analyze HPeV infections in Taiwanese children.
- To compare clinical outcomes between infants and older children.
- To investigate the role of hospital-acquired infections.
Main Methods:
- Retrospective analysis of 112 children (age ≤10 years) diagnosed with HPeV infection.
- Comparison of clinical data between children <3 months and ≥3 months old.
- Identification of HPeV genotypes and assessment of hospital-acquired infections.
Main Results:
- HPeV1 was the predominant genotype (n=94).
- Infants <3 months experienced less fever and respiratory symptoms but higher ICU admission rates and longer hospital stays compared to older children.
- Approximately one-third of cases were suspected hospital-acquired infections, with 42.9% in infants <3 months.
Conclusions:
- HPeV infections present distinct clinical patterns based on age in Taiwanese children.
- Hospital-acquired HPeV infections are a critical concern, especially for young infants.
- Age-specific management strategies and infection control measures are essential for HPeV in pediatric populations.
Abstract:
To understand human parechovirus (HPeV) infections in Taiwanese children, we analyzed data for 112 children (age≤10 years) with HPeV infection diagnosed between July 2007 and June 2016 in a medical center in Kaohsiung, southern Taiwan. The patients were infected with HPeV1 (n=94), HPeV3 (n=3), HPeV4 (n=3), HPeV6 (n=1) and non-typeable HPeV (n=11). We compared the clinical implications for children younger than 3 months (n=56) and 3 months and older (n=31), excluding 25 children with concomitant infections. Fever was noted in almost half of the children younger than 3 months but was more frequent in older than in younger children (83.9% vs 46.4%). As compared with older children, children younger than 3 months had a lower incidence of respiratory symptoms (30.1% vs 83.9%), more frequently required intensive care unit admission (28.6% vs 3.2%), and had longer hospital stays (mean 10.95 vs 5.13 days). Importantly, about one-third of the children were suspected to have hospital-acquired or cluster infections in the environment of medical institutions, with a significantly high proportion of 42.9% (24/56) in younger infants. Hospital-acquired infections might play a key role in the spread of HPeV, especially in children younger than 3 months.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Bioavailability Study Design: Single Versus Multiple Dose Studies
Drug Dosing: Infants and Children
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

